|
|
慢性阻塞性肺疾病急性加重合并肺栓塞的研究进展
|
Abstract:
慢性阻塞性肺疾病(慢阻肺)的发病率和死亡率呈上升趋势，慢阻肺严重危害人类的健康。大约30%的慢阻肺急性加重患者原因不明，其中相当一部分可能与合并肺栓塞有关。慢阻肺急性加重时临床表现与肺栓塞相似，确诊肺栓塞主要依靠计算机断层扫描肺血管造影(CTPA)，常规检查不易排除或确认肺栓塞，易被漏诊或过度检查，影响患者预后或增加患者负担。目前对慢阻肺合并肺栓塞的研究尚不充分，为尽早准确的筛查慢阻肺急性加重患者是否合并肺栓塞，本文从流行病学、危险因素、临床特征、预后及治疗等方面来描述，使临床医生对慢阻肺合并肺栓塞有系统的认识，进而规范诊治流程，减少漏诊、误诊。
The morbidity and mortality of chronic obstructive pulmonary disease (COPD) are on the rise, and COPD is seriously harmful to human health. About 30% of patients with acute exacerbstion of COPD have unknown causes, and a considerable number of them may be associated with pulmonary em-bolism. The clinical manifestations of acute exacerbation of COPD are similar to those of pulmonary embolism. The diagnosis of pulmonary embolism mainly depends on computed tomography pul-monary angiography (CTPA). Routine examination is not easy to exclude or confirm pulmonary embolism, and it is easy to be missed or overexamined, affecting the prognosis or increasing the burden of patients. At present, the research on COPD with pulmonary embolism is not enough. In order to screen the acute exacerbation of COPD with pulmonary embolism as soon as possible, this paper describes it from the aspects of epidemiology, risk factors, clinical characteristics, prognosis and treatment, so that clinicians have a systematic understanding of COPD patients with pulmonary embolism, standardize the process of diagnosis and treatment, and reduce missed diagnosis and misdiagnosis.
| [1] | Wang, C., Xu, J., Yang, L., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717.
https://doi.org/10.1016/S0140-6736(18)30841-9 |
| [2] | B？rvik, T., Br？kkan, S.K., Enga, K., et al. (2016) COPD and Risk of Venous Thromboembolism and Mortality in a General Population. The European Respiratory Journal, 47, 473-481. https://doi.org/10.1183/13993003.00402-2015 |
| [3] | Harenberg, J. and Verhamme, P. (2020) The Dan-gerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism. Thrombosis and Haemostasis, 120, 363-365. https://doi.org/10.1055/s-0039-1701012 |
| [4] | Aleva, F.E., Voets, L., Simons, S.O., et al. (2017) Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Sys-tematic Review and Meta-Analysis. Chest, 151, 544-554.
https://doi.org/10.1016/j.chest.2016.07.034 |
| [5] | Wang, J., Wan, Z., Liu, Q., et al. (2020) Predictive Value of Red Blood Cell Distribution Width in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Embolism. Analytical Cellular Pathology (Amsterdam), 2020, 1935742-1935748. https://doi.org/10.1155/2020/1935742 |
| [6] | Pourmand, A., Robinson, H., Mazer-Amirshahi, M., et al. (2018) Pulmonary Embolism among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Implications for Emergency Medicine. The Journal of Emergency Medicine, 55, 339-346. https://doi.org/10.1016/j.jemermed.2018.05.026 |
| [7] | Akpinar, E.E., Hosgun, D., Akpinar, S., et al. (2014) Incidence of Pulmonary Embolism during COPD Exacerbation. Jornal Brasileiro de Pneumologia, 40, 38-45. https://doi.org/10.1590/S1806-37132014000100006 |
| [8] | Hassen, M.F., Tilouche, N., Jaoued, O., et al. (2019) In-cidence and Impact of Pulmonary Embolism during Severe COPD Exacerbation. Respiratory Care, 64, 1531-1536. https://doi.org/10.4187/respcare.06661 |
| [9] | Jing, X., Zhang, G., Zhang, B., et al. (2018) Efficacy and Safety of Low-Dose Urokinase for the Treatment of Hemodynamically Stable AECOPD Patients with Acute Pulmonary Throm-boembolism. The Clinical Respiratory Journal, 12, 1882-1890. https://doi.org/10.1111/crj.12751 |
| [10] | Wang, J. and Ding, Y.M. (2021) Prevalence and Risk Factors of Pulmonary Embolism in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Impact on Outcomes: A Systematic Review and Meta-Analysis. European Review for Medi-cal and Pharmacological Sciences, 25, 2604-2616. |
| [11] | Dentali, F., Pomero, F., Micco, P.D., et al. (2020) Prevalence and Risk Factors for Pulmonary Embolism in Patients with Suspected Acute Exacerbation of COPD: A Multi-Center Study. European Journal of Internal Medicine, 80, 54-59. https://doi.org/10.1016/j.ejim.2020.05.006 |
| [12] | De-Miguel-Diez, J., Albaladejo-Vicente, R., Jimenez-Garcia, R., et al. (2021) The Effect of COPD on the Incidence and Mortality of Hospitalized Patients with Pulmonary Embolism: A Nationwide Population-Based Study (2016-2018). European Journal of Internal Medicine, 84, 18-23. https://doi.org/10.1016/j.ejim.2020.11.009 |
| [13] | Jindal, A., Rathore, Y.S., Joshi, V., et al. (2020) A Cross-Sectional Study for the Evaluation of Pulmonary Embolism in Unexplained Dyspnea in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Indian Journal of Respiratory Care, 9, 191-195. |
| [14] | Yang, R., Liu, G. and Deng, C. (2021) Pul-monary Embolism with Chronic Obstructive Pulmonary Disease. Chronic Diseases and Translational Medicine, 7, 149-156. https://doi.org/10.1016/j.cdtm.2021.04.001 |
| [15] | Joaquín, M.F., Matías, C.H., De Vito Eduardo, L., et al. (2020) Diagnosis of Pulmonary Embolism in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Dis-ease: A Cross-Sectional Study. The Clinical Respiratory Journal, 14, 1176-1181. https://doi.org/10.1111/crj.13257 |
| [16] | Pang, H., Wang, L., Liu, J., et al. (2018) The Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The Clinical Respiratory Journal, 12, 2573-2580. https://doi.org/10.1111/crj.12959 |
| [17] | Davoodi, M., Rezvankhah, B., Gohari Moghadam, K., et al. (2018) The Prevalence and Predicting Factors of Pulmonary Thromboembolism in Pa-tients with Exacerbated Chronic Obstructive Pulmonary Disease. Advances in Respiratory Medicine. https://doi.org/10.5603/ARM.a2018.0025 |
| [18] | Fu, X., Zhong, Y., Xu, W., et al. (2021) The Prevalence and Clini-cal Features of Pulmonary Embolism in Patients with AE-COPD: A Meta-Analysis and Systematic Review. PLOS ONE, 16, e256480.
https://doi.org/10.1371/journal.pone.0256480 |
| [19] | Couturaud, F., Bertoletti, L., Pastre, J., et al. (2021) Prevalence of Pulmonary Embolism among Patients with COPD Hospitalized with Acutely Worsening Respiratory Symptoms. JAMA, 325, 59-68.
https://doi.org/10.1001/jama.2020.23567 |
| [20] | Woller, S.C., Stevens, S.M., Adams, D.M., et al. (2014) Assessment of the Safety and Efficiency of Using an Age-Adjusted D-Dimer Threshold to Exclude Suspected Pulmonary Embolism. Chest, 146, 1444-1451.
https://doi.org/10.1378/chest.13-2386 |
| [21] | Bia？as, A.J., Kornicki, K., Ciebiada, M., et al. (2018) Monocyte to Large Platelet Ratio as a Diagnostic Tool of Pulmonary Embolism in Patients with Acute Exacerbation of COPD—Pilot Study. Polish Archives of Internal Medicine, 128, 15-23. https://doi.org/10.20452/pamw.4141 |
| [22] | Wang, M., Zhang, J., Ji, Q., et al. (2016) Evaluation of Platelet Distribution Width in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Embolism. Biomarkers in Medicine, 10, 587-596.
https://doi.org/10.2217/bmm.15.112 |
| [23] | Peng, L., Han, L., Li, X., et al. (2020) The Predictive Value of mi-croRNA-134 and microRNA-1233 for the Early Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Pulmonary Embolism. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2495-2503. https://doi.org/10.2147/COPD.S266021 |
| [24] | Hemnes, A.R., Newman, A.L., Rosenbaum, B., et al. (2010) Bedside End-Tidal CO2 Tension as a Screening Tool to Exclude Pulmonary Embolism. European Respiratory Journal, 35, 735-741.
https://doi.org/10.1183/09031936.00084709 |
| [25] | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2023 Report. https://goldcopd.org/2023-gold-report-2/ |
| [26] | Rastoder, E., Sivapalan, P., Eklof, J., et al. (2021) Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients. Biomedicines, 9, 874.
https://doi.org/10.3390/biomedicines9080874 |
| [27] | 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087.
https://doi.org/10.3760/cma.j.issn.0376-2491.2018.14.007 |
| [28] | Konstantinides, S.V., Meyer, G., Becattini, C., et al. (2019) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Col-laboration with the European Respiratory Society (ERS): THE Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Respiratory Journal, 54, Article ID: 1901647. https://doi.org/10.1183/13993003.01647-2019 |
| [29] | 杜静, 朱述阳. 瑞替普酶联合华法林在慢性阻塞性肺疾病合并急性中危肺栓塞治疗中的有效性[J]. 中国临床医学, 2020, 27(5): 827-830. https://doi.org/10.12025/j.issn.1008-6358.2020.20201195 |
| [30] | Jimenez, D., Agusti, A., Tabernero, E., et al. (2021) Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerba-tion: A Randomized Clinical Trial. JAMA, 326, 1277-1285.
https://doi.org/10.1001/jama.2021.14846 |
| [31] | Gupta, R., Ammari, Z., Dasa, O., et al. (2020) Long-Term Mortality after Massive, Submassive, and Low-Risk Pulmonary Embolism. Vascular Medicine, 25, 141-149. https://doi.org/10.1177/1358863X19886374 |
| [32] | Guo, L., Chughtai, A.R., Jiang, H., et al. (2016) Relationship between Polycythemia and In-Hospital Mortality in Chronic Obstructive Pulmonary Disease Patients with Low-Risk Pulmonary Embolism. Journal of Thoracic Disease, 8, 3119-3131. https://doi.org/10.21037/jtd.2016.11.31 |
| [33] | 郭璐, 杨阳, 蒋红丽, 等. 血小板增多与慢性阻塞性肺疾病伴低危肺栓塞患者住院全因死亡的相关性分析[J]. 中国呼吸与危重监护杂志, 2018, 17(1): 20-26. https://doi.org/10.7507/1671-6205.201708041 |
